Private: QOF Disease Prevalence
COPD is the second largest cause of emergency hospital admissions in the UK.
Each year, approximately 1 million bed days are accounted for by COPD patients.
Through our Clinical Pharmacists, Interface can support in the systematic management of patients with COPD to reduce symptoms and the risk of exacerbations and therefore referrals on to secondary care.
Get in touch to discuss COPD Therapy further or apply here directly
Need some help? Get in touch
Using your practice clinical system and specially designed searches Interface can:
The pharmacist will identify COPD patients with persistent symptoms but not showing significant exacerbations. These patients can then be reviewed and action plans produced to manage their treatment going forward.
Patients with minimal symptoms & significant exacerbations, and COPD patients with persistent symptoms & significant exacerbations, will also be reviewed against national guidelines.
Those with a hospital admission managed outside of local guidelines will be identified and flagged to the practice for further review. Detailed dashboards are presented at baseline and on completion to support Quality Improvement initiatives and PDSA cycles. Our therapy reviews can be funded at no additional cost to the practice, as we work in partnership with practices and PCNs, to help manage the additional burden as a result of the COVID pandemic.
Catherine Forrest, Practice Manager, Beechwood Surgery, Fylde and Wyre CCG
Find out more
Our Clinical Pharmacists are now able to offer coding support across a number of QOF domains